Dermatology
News
Recombinant IL-2 shows potential in atopic dermatitis
Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is...
News
Treatment options for vitiligo reviewed
Principles of vitiligo treatment are to stop immune destruction and to stimulate melanocyte differentiation, migration, and melanin production, Dr...
News
FDA proposes ban on hair straightener ingredients
The proposal specifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.
News
Once-weekly topical therapy shows promise for moderate to severe acne
In vitro studies have found that components of S. lacustris, a freshwater sponge, have effects that include antimicrobial activity...
News
FDA approves nivolumab for resected stage IIB/C melanoma
Approval was based on findings from a phase 3 trial, which randomly assigned 790 patients to receive nivolumab or placebo by intravenous infusion...
News
Pilot study: High-dose IL-23 inhibition shows promise for psoriasis remission in some patients
Targeting resident memory T cells may be a key to long-term remission.
News
Roflumilast side effect benefits patients with psoriasis and overweight/obesity
An “extraordinary” finding was how some patients’ weight status based on their BMI changed throughout the study.
News
Novel triple-threat approach to acne beats placebo
Patients in the IDP-126 groups for both studies 1 and 2 had significantly greater absolute mean reductions in both inflammatory and...
Article
Painful heels
Commentary
Atopic dermatitis: Five things to know
The incidence of AD has increased over the past several decades, and environmental factors such as climate change have been implicated as a...